ketanserin has been researched along with Alcohol Withdrawal Associated Autonomic Hyperactivity in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grant, KA | 1 |
| Hellevuo, K | 1 |
| Tabakoff, B | 1 |
| Ulrichsen, J | 1 |
2 other studies available for ketanserin and Alcohol Withdrawal Associated Autonomic Hyperactivity
| Article | Year |
|---|---|
The 5-HT3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice.
Topics: Alcohol Withdrawal Delirium; Animals; Dose-Response Relationship, Drug; Electroencephalography; Evok | 1994 |
Alterations in serotonin receptor subtypes in ethanol-dependent rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alcohol Withdrawal Delirium; Alcoholic Intoxication; Alcohol | 1991 |